{"transactions":[{"id":951652,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:33:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant vests in full upon the earlier of (i) June 10, 2026 or (ii) the date of the next annual meeting of the Company's stockholders."}],"balance_after":90000,"derivative":{"exercise_price":5.17,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001171843-26-000057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326000057/ownership.xml","form_type":"4"}},{"id":1236048,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T23:30:08.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date."}],"balance_after":55000,"derivative":{"exercise_price":30.17,"expiration_date":"2035-03-02","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-25-031148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025031148/ownership.xml","form_type":"4"}},{"id":1236047,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T23:30:08.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":408,"price":31.0046,"value":12649.8768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $31.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":80085,"source":{"system":"sec-edgar","filing":"0000950170-25-031148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025031148/ownership.xml","form_type":"4"}},{"id":1236046,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T23:30:08.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":1833,"price":30.3271,"value":55589.5743,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $30.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":80493,"source":{"system":"sec-edgar","filing":"0000950170-25-031148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025031148/ownership.xml","form_type":"4"}},{"id":1236045,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T23:30:08.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date."}],"balance_after":82326,"source":{"system":"sec-edgar","filing":"0000950170-25-031148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025031148/ownership.xml","form_type":"4"}},{"id":1269701,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:09:52.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 11, 2025."}],"balance_after":40000,"derivative":{"exercise_price":3.65,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-25-000826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325000826/ownership.xml","form_type":"4"}},{"id":1310901,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-06T22:00:04.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":3129,"price":41.7529,"value":130644.8241,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $41.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 1,203 shares and 792 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024 and December 1, 2024, respectively."}],"balance_after":54826,"source":{"system":"sec-edgar","filing":"0000950170-25-002266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025002266/ownership.xml","form_type":"4"}},{"id":1603451,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T23:15:16.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":130531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date."}],"balance_after":130531,"derivative":{"exercise_price":43.5,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130531},"source":{"system":"sec-edgar","filing":"0000950170-24-025093","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024025093/ownership.xml","form_type":"4"}},{"id":1603450,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-04T23:15:16.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":21755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date."}],"balance_after":55960,"source":{"system":"sec-edgar","filing":"0000950170-24-025093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024025093/ownership.xml","form_type":"4"}},{"id":1643242,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T17:01:10.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 9, 2024."}],"balance_after":40000,"derivative":{"exercise_price":1.57,"expiration_date":"2034-02-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-24-000793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184324000793/ownership.xml","form_type":"4"}},{"id":1685623,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-05T22:15:06.000Z","date":"2024-01-04","kind":"sale","planned":false,"acquired":false,"shares":3295,"price":22.5844,"value":74415.598,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $22.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34205,"source":{"system":"sec-edgar","filing":"0000950170-24-002536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024002536/ownership.xml","form_type":"4"}},{"id":2024831,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T21:31:41.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 8, 2023."}],"balance_after":40000,"derivative":{"exercise_price":3.93,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-23-000855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184323000855/ownership.xml","form_type":"4"}},{"id":2068359,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:35:15.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option shall vest on January 3, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":24.84,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-23-000630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924323000630/doc4.xml","form_type":"4"}},{"id":2068358,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-01-04T21:35:15.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following January 3, 2023, subject to the reporting person's continued employment through each vesting date."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0000899243-23-000630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924323000630/doc4.xml","form_type":"4"}},{"id":2288794,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-28T17:29:38.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in substantially equal monthly installments over four years."}],"balance_after":45000,"derivative":{"exercise_price":1.51,"expiration_date":"2032-04-25","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001171843-22-002945","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184322002945/ownership.xml","form_type":"4"}},{"id":2626551,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:40:38.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":116850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC.  In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899866-21-000068","document":"wf-form4_162707282278233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000068/wf-form4_162707282278233.xml","form_type":"4"}},{"id":2632532,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:46:49.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":27657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan."}],"balance_after":116850,"source":{"system":"sec-edgar","filing":"0000899866-21-000053","document":"wf-form4_162646839305869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000053/wf-form4_162646839305869.xml","form_type":"4"}},{"id":2632531,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:46:49.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":26812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan."}],"balance_after":89193,"source":{"system":"sec-edgar","filing":"0000899866-21-000053","document":"wf-form4_162646839305869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000053/wf-form4_162646839305869.xml","form_type":"4"}},{"id":2822833,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-03-02T17:57:30.000Z","date":"2021-02-28","kind":"grant","acquired":true,"shares":19321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":62381,"source":{"system":"sec-edgar","filing":"0000899866-21-000027","document":"wf-form4_161472583224710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000027/wf-form4_161472583224710.xml","form_type":"4"}},{"id":2938542,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:02:55.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":56,"price":95.53,"value":5349.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In accordance with the Alexion ESPP, these shares were purchased (for the ESPP purchase period from July 1, 2020 to December 15, 2020) based on 85% of the share price on July 1, 2020."}],"balance_after":43060,"source":{"system":"sec-edgar","filing":"0000899866-20-000091","document":"wf-form4_160832896191217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000091/wf-form4_160832896191217.xml","form_type":"4"}},{"id":2938541,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:02:55.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":2988,"price":157.96,"value":471984.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":43004,"source":{"system":"sec-edgar","filing":"0000899866-20-000091","document":"wf-form4_160832896191217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000091/wf-form4_160832896191217.xml","form_type":"4"}},{"id":2938540,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:02:55.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":16925,"price":157.96,"value":2673473.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."}],"balance_after":45992,"source":{"system":"sec-edgar","filing":"0000899866-20-000091","document":"wf-form4_160832896191217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000091/wf-form4_160832896191217.xml","form_type":"4"}},{"id":2938539,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:02:55.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":37965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan."}],"balance_after":62917,"source":{"system":"sec-edgar","filing":"0000899866-20-000091","document":"wf-form4_160832896191217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000091/wf-form4_160832896191217.xml","form_type":"4"}},{"id":3234906,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:31:45.000Z","date":"2019-12-15","kind":"grant","acquired":true,"shares":54,"price":93.86,"value":5068.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In accordance with the Alexion ESPP, these shares were purchased (for the ESPP purchase period from June 30, 2019 to December 15, 2019) based on 85% of the closing price of the Issuer's common stock on December 15, 2019."}],"balance_after":24952,"source":{"system":"sec-edgar","filing":"0000899866-20-000026","document":"wf-form4_158327828887030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000026/wf-form4_158327828887030.xml","form_type":"4"}},{"id":3234905,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:31:45.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":1263,"price":90.54,"value":114352.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.48 - $92.25.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":24898,"source":{"system":"sec-edgar","filing":"0000899866-20-000026","document":"wf-form4_158327828887030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000026/wf-form4_158327828887030.xml","form_type":"4"}},{"id":3234904,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:31:45.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":26161,"source":{"system":"sec-edgar","filing":"0000899866-20-000026","document":"wf-form4_158327828887030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000026/wf-form4_158327828887030.xml","form_type":"4"}},{"id":3615632,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-05T20:14:44.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":15961,"source":{"system":"sec-edgar","filing":"0000899866-19-000046","document":"wf-form4_155183486992229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000046/wf-form4_155183486992229.xml","form_type":"4"}},{"id":3620734,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-04T17:43:52.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":633,"price":132.92,"value":84138.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $134.74.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":7711,"source":{"system":"sec-edgar","filing":"0000899866-19-000042","document":"wf-form4_155173940527059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000042/wf-form4_155173940527059.xml","form_type":"4"}},{"id":4021787,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-02T17:01:55.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":8344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":8344,"source":{"system":"sec-edgar","filing":"0000899866-18-000062","document":"wf-form4_152002809787521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000062/wf-form4_152002809787521.xml","form_type":"4"}},{"id":4195069,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Restricted Stock Units","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":19470,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19470},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195068,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":36.74,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195067,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":11788,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":25.68,"underlying":"Common Stock","underlying_shares":11788},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195066,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":975,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":25.43,"underlying":"Common Stock","underlying_shares":975},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195065,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":5250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":37.42,"underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195064,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":45.47,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195063,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":26.06,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195062,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":38.01,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195061,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":8331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option."}],"balance_after":0,"derivative":{"exercise_price":35.58,"underlying":"Common Stock","underlying_shares":8331},"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4195060,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-10-03T17:31:11.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":32764,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the \"Merger Agreement\"), between Alere Inc. (the \"Company\") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock (the \"Common Stock\") was converted into the right to receive $51.00 (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-001779","document":"es1701004_4-chiniara.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000095014217001779/es1701004_4-chiniara.xml","form_type":"4"}},{"id":4218062,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Restricted Stock Units","published_at":"2017-09-05T19:43:10.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-17-012033","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017012033/edgar.xml","form_type":"4"}},{"id":4218061,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-09-05T19:43:10.000Z","date":"2017-08-31","kind":"tax_withholding","acquired":false,"shares":2163,"price":49.46,"value":106981.98,"ownership":{"direct":true},"balance_after":32764,"source":{"system":"sec-edgar","filing":"0001179110-17-012033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017012033/edgar.xml","form_type":"4"}},{"id":4218060,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-09-05T19:43:10.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."}],"balance_after":34927,"source":{"system":"sec-edgar","filing":"0001179110-17-012033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017012033/edgar.xml","form_type":"4"}},{"id":4436373,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Restricted Stock Units","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":7236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 16, 2016 the reporting person was granted 21,706 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 16, 2016 the reporting person was granted 21,706 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19)."}],"balance_after":14470,"derivative":{"underlying":"Common Stock","underlying_shares":7236},"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4436372,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Restricted Stock Units","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 16, 2016 the reporting person was granted 7,500 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 16, 2016 the reporting person was granted 7,500 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19)."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4436371,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":2432,"price":40.4,"value":98252.8,"ownership":{"direct":true},"balance_after":28260,"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4436370,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":7236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."}],"balance_after":30692,"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4436369,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":811,"price":40.4,"value":32764.4,"ownership":{"direct":true},"balance_after":23456,"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4436368,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-02-21T18:08:07.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."}],"balance_after":24267,"source":{"system":"sec-edgar","filing":"0001179110-17-002822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002822/edgar.xml","form_type":"4"}},{"id":4446049,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2017-02-15T17:58:43.000Z","date":"2016-11-30","kind":"other","acquired":true,"shares":238,"price":33.728,"value":8027.264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities were acquired under the Alere Inc. Employee Stock Purchase Plan. This transaction, which is exempt from Section 16(b) by virtue of Rule 16b-3(c), is being voluntarily reported."}],"balance_after":21767,"source":{"system":"sec-edgar","filing":"0001179110-17-002459","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911017002459/edgar.xml","form_type":"5"}},{"id":4578406,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This derivative security does not have a price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options became exercisable in four equal annual installments beginning October 16, 2007."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Options were scheduled to expire on October 15, 2016."}],"balance_after":0,"derivative":{"exercise_price":37.74,"expiration_date":"2016-10-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578405,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":false,"shares":9404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This derivative security does not have a price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options became exercisable in four equal annual installments beginning October 16, 2007."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Options were scheduled to expire on October 15, 2016."}],"balance_after":0,"derivative":{"exercise_price":37.74,"expiration_date":"2016-10-15","underlying":"Common Stock","underlying_shares":9404},"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578404,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":false,"shares":7096,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This derivative security does not have a price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options became exercisable in four equal annual installments beginning October 16, 2007."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Options were scheduled to expire on October 15, 2016."}],"balance_after":0,"derivative":{"exercise_price":37.74,"expiration_date":"2016-10-15","underlying":"Common Stock","underlying_shares":7096},"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578403,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":false,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This derivative security does not have a price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options became exercisable in four equal annual installments beginning October 16, 2007."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Options were scheduled to expire on October 15, 2016."}],"balance_after":7096,"derivative":{"exercise_price":37.74,"expiration_date":"2016-10-15","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578402,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"tax_withholding","acquired":false,"shares":4393,"price":42.95,"value":188679.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above."}],"balance_after":21529,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578401,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":true,"shares":5000,"price":37.74,"value":188700.0,"ownership":{"direct":true},"balance_after":25922,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578400,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"tax_withholding","acquired":false,"shares":8263,"price":42.95,"value":354895.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above."}],"balance_after":20922,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578399,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":true,"shares":9404,"price":37.74,"value":354906.96,"ownership":{"direct":true},"balance_after":29185,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578398,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"tax_withholding","acquired":false,"shares":6235,"price":42.95,"value":267793.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above."}],"balance_after":19781,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578397,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":true,"shares":7096,"price":37.74,"value":267803.04,"ownership":{"direct":true},"balance_after":26016,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4578396,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-10-18T17:40:51.000Z","date":"2016-10-14","kind":"exercise","acquired":true,"shares":3500,"price":37.74,"value":132090.0,"ownership":{"direct":true},"balance_after":18920,"source":{"system":"sec-edgar","filing":"0001179110-16-030772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016030772/edgar.xml","form_type":"4"}},{"id":4604541,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Restricted Stock Units","published_at":"2016-09-13T17:23:19.000Z","date":"2016-09-09","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17)."}],"balance_after":6667,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-16-029613","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016029613/edgar.xml","form_type":"4"}},{"id":4604540,"issuer":{"id":172772,"kind":"organization","name":"ALERE INC.","symbol":"ALR"},"owners":[{"id":70329,"kind":"person","name":"Chiniara Ellen","position":1,"cik":"0001398764","reported_name":"Chiniara Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Chief Ethics Officer&Sec"}}],"security":"Common Stock","published_at":"2016-09-13T17:23:19.000Z","date":"2016-09-09","kind":"exercise","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Vesting of shares under the Alere 2010 Stock Option and Incentive Plan was suspended from March 1, 2016 until two business days after Alere's SEC filings became current.  Shares vested on September 9, 2016 represent shares that otherwise would have vested during the suspension period."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Alere common stock."}],"balance_after":15420,"source":{"system":"sec-edgar","filing":"0001179110-16-029613","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145460/000117911016029613/edgar.xml","form_type":"4"}}]}